Skip to content

GDTC CYTOMED THERAPEUTICS LIMITED

Follow

SHS (common), issuer CIK 1873093

5 managers (5 13F filers) reported a position in GDTC shares at 2025-12-31, 53,128 shares in all. 4 filers opened a position and 1 filer sold out during the quarter.

Managers
5
13F filers
5
New
4
Added
0
Reduced
1
Sold out
1
Shares held by filers
53,128

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q4 2025

Filers in the available 13F reports with a share position at 2025-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
SUSQUEHANNA INTERNATIONAL GROUP, LLPin group SUSQUEHANNA INTERNATIONAL GRO…29,829$39.7K<0.01%new13F-HRTimelineGroup
TWO SIGMA SECURITIES, LLC11,857$15.8K<0.01%new13F-HRTimeline
StoneX Group Inc.in group StoneX Group Inc.10,356$13.8K<0.01%new13F-HRTimelineGroup
UBS Group AGin group UBS Group AG1,065$1.42K<0.01%-12,22413F-HRTimelineGroup
OSAIC HOLDINGS, INC.in group OSAIC HOLDINGS, INC.21$28<0.01%new13F-HRTimelineGroup